Polymeric Systems for Colon-specific Mesalazine Delivery in the Intestinal Bowel Diseases Management
Authors:
- Alberto Gomes Tavares JuniorAlberto Gomes Tavares Junior
- Jennifer Thayanne Cavalcante de AraújoJAJennifer Thayanne Cavalcante de Araújo
- Jonatas Lobato DuarteJonatas Lobato Duarte
- Amanda Letícia Polli SilvestreASAmanda Letícia Polli Silvestre
- Leonardo Delello Di FilippoLFLeonardo Delello Di Filippo
- Marlus ChorilliMarlus Chorilli
- 1 April 2023
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 30 (12) , 1351-1367
Abstract
The anti-inflammatory 5-aminosalicylic acid (5-ASA) is the main therapeutic option used in the prevention and treatment of inflammatory bowel diseases. The upper intestinal tract performs rapid and almost complete absorption of this drug when administered orally., making local therapeutic levels of the molecule in the inflamed colonic mucosa difficult to achieve. Micro and nanoparticle systems are promising for 5-ASA incorporation because the reduced dimensions of these structures can improve the drug's pharmacodynamics and contribute to more efficient and localized therapy. Together, the association of these systems with polymers will allow the release of 5-ASA through specific targeting mechanisms to the colon, as demonstrated in mesalazine modified-release dosage form. In this review, the challenges for the oral administration of 5-ASA and the different colon-specific delivery strategies using polymers will be summarized and discussed.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/19228-8, 2019/25125-7, 2020/06212-3)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (001)
This publication has 86 references indexed in Scilit:
- Moisturizing effect of a cosmetic formulation containing pequi oil (Caryocar brasiliense) from the Brazilian cerrado biomeBrazilian Journal of Pharmaceutical Sciences, 2014
- Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosaJournal of Controlled Release, 2012
- Gelatin tannate reduces the proinflammatory effects of lipopolysaccharide in human intestinal epithelial cellsClinical and Experimental Gastroenterology, 2012
- Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysisAlimentary Pharmacology & Therapeutics, 2011
- N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: In vivo study with TNBS-induced colitis model in ratsInternational Journal of Pharmaceutics, 2011
- The Effect of Chitosan as Internal or External Coating on the 5-ASA Release from Calcium Alginate MicroparticlesAAPS PharmSciTech, 2010
- Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: Influence of the core composition on release characteristicsPharmaceutical Development and Technology, 2010
- Poly(ethylene glycol)-mesalazine conjugate for colon specific deliveryInternational Journal of Pharmaceutics, 2009
- 5-ASA loaded chitosan–Ca–alginate microparticles: Preparation and physicochemical characterizationInternational Journal of Pharmaceutics, 2007
- Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticlesInternational Journal of Pharmaceutics, 2007